Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of hematotherapy

Showing results (91-100 of 369) with videos related to

Pageof 37
Sort By:
Journal of Hematotherapy|November 22, 1997
Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemiaS F Vervoordeldonk, H van den Berg, A E von dem Borne, et al.
Journal of Hematotherapy|June 1, 1999
Fetal cord blood as an alternative source of hematopoietic progenitor cells: immunophenotype, maternal cell contamination, and ex vivo expansionH Engel, E Kaya, R Bald, et al.
Journal of Hematotherapy|June 1, 1999
G-CSF-mobilized leukapheresis products: cellular characteristics and clinical performance in allograftingD Dłubek, T Pacuszko, K Suchnicki, et al.
Journal of Hematotherapy|June 1, 1999
Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilizationY Gazitt, C O Freytes, N Callander, et al.
Journal of Hematotherapy|June 1, 1999
Clinical scale expansion of cryopreserved small volume whole bone marrow aspirates produces sufficient cells for clinical useB I Lundell, R K Mandalam, A K Smith
Journal of Hematotherapy|June 1, 1999
The relation between the number of PBSC and number of leukaphereses in childrenT Kajiume, S Yoshimi, K Kobayashi, et al.
Journal of Hematotherapy|July 23, 1999
Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapseM Wiesneth, T Schreiner, D Bunjes, et al.
Journal of Hematotherapy|July 23, 1999
Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorptionD Skiera, W Zeller, A R Zander
Journal of Hematotherapy|April 7, 1999
Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistryJ A López-Guerrero, P B Gilabert, E B González, et al.
Journal of Hematotherapy|April 7, 1999
A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell graftsB Björkstrand, B Sundman-Engberg, B Christensson, et al.
Pageof 37

Showing results (91-100 of 369) with videos related to

Sort By:
Pageof 37
Journal of Hematotherapy|November 22, 1997
Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemiaS F Vervoordeldonk, H van den Berg, A E von dem Borne, et al.
Journal of Hematotherapy|June 1, 1999
Fetal cord blood as an alternative source of hematopoietic progenitor cells: immunophenotype, maternal cell contamination, and ex vivo expansionH Engel, E Kaya, R Bald, et al.
Journal of Hematotherapy|June 1, 1999
G-CSF-mobilized leukapheresis products: cellular characteristics and clinical performance in allograftingD Dłubek, T Pacuszko, K Suchnicki, et al.
Journal of Hematotherapy|June 1, 1999
Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilizationY Gazitt, C O Freytes, N Callander, et al.
Journal of Hematotherapy|June 1, 1999
Clinical scale expansion of cryopreserved small volume whole bone marrow aspirates produces sufficient cells for clinical useB I Lundell, R K Mandalam, A K Smith
Journal of Hematotherapy|June 1, 1999
The relation between the number of PBSC and number of leukaphereses in childrenT Kajiume, S Yoshimi, K Kobayashi, et al.
Journal of Hematotherapy|July 23, 1999
Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapseM Wiesneth, T Schreiner, D Bunjes, et al.
Journal of Hematotherapy|July 23, 1999
Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorptionD Skiera, W Zeller, A R Zander
Journal of Hematotherapy|April 7, 1999
Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistryJ A López-Guerrero, P B Gilabert, E B González, et al.
Journal of Hematotherapy|April 7, 1999
A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell graftsB Björkstrand, B Sundman-Engberg, B Christensson, et al.
Pageof 37